![Stefan Rehnmark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Rehnmark
Technik-/Wissenschafts-/F&E-Leiter bei
GABATHER AB
Profil
Stefan Rehnmark is the founder of Axcentua Pharmaceuticals AB, which was founded in 2007.
He held the title of Chief Executive & Scientific Officer at the company.
Dr. Rehnmark is also the founder of Noviga Research AB. Dr. Rehnmark's current job(s) include being a Director at LIDDS AB since 2024 and serving as the Chief Scientific Officer at Gabather AB. Dr. Rehnmark's former job was as an Assistant Professor at the University of Stockholm from 1994 to 2000.
Dr. Rehnmark obtained a doctorate degree from the University of Stockholm.
Aktive Positionen von Stefan Rehnmark
| Unternehmen | Position | Beginn |
|---|---|---|
| GABATHER AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
| LIDDS AB | Direktor/Vorstandsmitglied | 27.05.2024 |
Ehemalige bekannte Positionen von Stefan Rehnmark
| Unternehmen | Position | Ende |
|---|---|---|
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1998 |
Noviga Research AB | Gründer | - |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs for pancreatic cancer | Vorstandsvorsitzender | - |
Ausbildung von Stefan Rehnmark
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs for pancreatic cancer | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Gabather AB
 Gabather AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops mental health drugs | Health Technology |
Noviga Research AB |
